InflaRx N.V.

IFRX

Held by 1 specialist biotech fund

High short interest · No specialist buying

Share on X

Fund Holdings

RA Capital Management

Position history (shares)

RA Capital Management

2Q

2 quarters

Position Trend

Aug 14, 2025

$1.6M

1 fund

Nov 14, 2025

$2.6M

1 fund

Feb 17, 2026

$0

0 funds

-100% total institutional value over 3 quarters

Short Interest

High short interest

Short Shares

2.56M

Change

-8.4%

Days to Cover

13.3

% of Float

4.0%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Activist Filings

SC 13G/ARA Capital Management0.0%Jul 10, 2019

SC 13G/ARA Capital Management10.8%Apr 10, 2019

SC 13G/ARA Capital Management8.0%Feb 14, 2019

Position Details

RA Capital ManagementEXITFeb 17, 2026

Shares: 1,973,233Value: $2.6M

RA Capital ManagementINCREASENov 14, 2025

Shares: 1,973,233Value: $2.6M

+ 1more — see how much conviction went in

See the Full Story

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

VOR1 fund BCRX1 fund BLTE1 fund CAPR1 fund CCCC1 fund CTNM1 fund DSGN1 fund CLYM1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: